• RBC Capital sets a price target of $860 for AXON, indicating a potential increase of 55.13%.
• Connected Devices segment revenue up by 24% year over year to $405 million in Q3 2025, driven by TASER 10 and Axon Body 4 camera.
• Despite a slight decrease in stock price, AXON's market capitalization remains strong at approximately $43.75 billion.

Axon Enterprise, Inc. (NASDAQ:AXON) is a leading provider of public safety technology, known for its innovative products like TASER devices and body cameras. The company is experiencing significant growth, particularly in its Connected Devices segment. On November 17, 2025, RBC Capital set a price target of $860 for AXON, suggesting a potential price increase of 55.13% from its current price of $554.37.

Axon's Connected Devices segment is thriving, with revenues rising by 24% year over year to $405 million in Q3 2025. This growth is driven by strong demand for the TASER 10 and the Axon Body 4 camera. The TASER and Personal Sensors businesses grew by 17% and 20%, respectively, while the Platform Solutions segment saw a remarkable 71% increase.

The TASER 10, which began shipping in 2023, and the Axon Body 4 camera, launched in April 2023, are key contributors to Axon's success. The Axon Body 4 camera features advanced capabilities like bi-directional communication and a point-of-view camera module, leading to strong order volumes. These innovations support the expansion of Axon's product portfolio.

Despite a slight decrease of 0.52% or $2.92 in its stock price, AXON's market capitalization remains robust at approximately $43.75 billion. The stock has traded between $546.64 and $569.04 today, with a 52-week high of $885.92 and a low of $469.24. The trading volume on the NASDAQ is 823,617 shares, indicating active investor interest.